Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination

Clinical and Vaccine Immunology

Volumn 20, Issue 9, 2013, Pages 1388-1395

  Schure, Rose Minke ^a,b   Hendrikx, Lotte H ^c   De Rond, Lia G H ^a   Öztürk, Kemal ^a   Sanders, Elisabeth A M ^b   Berbers, Guy A M ^a   Buisman, Anne Marie ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; FILAMENTOUS HEMAGGLUTININ ADHESIN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; INFANRIX IPV; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 5; PERTACTIN; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LYMPHOCYTE COUNT; MALE; MEMORY CELL; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVACCINATION; T LYMPHOCYTE;

ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; PERTUSSIS VACCINE; T-LYMPHOCYTES; VACCINES, ACELLULAR; VACCINES, INACTIVATED; WHOOPING COUGH;

EID: 84884697487     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00270-13     Document Type: Article

References (41)

1. de Greeff SC, Schellekens JF, Mooi FR, de Melker HE. 2005. Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003. Ned. Tijdschr. Geneeskd. 149:937-943. (In Dutch.)
2. Guiso N, Njamkepo E, Vie le Sage F, Zepp F, Meyer CU, Abitbol V, Clyti N, Chevallier S. 2007. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 25:1390-1397.
3. Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM. 2009. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine 27:6530-6536.
4. Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF. 2013. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens. Vaccine. [Epub ahead of print.] doi:10.1016/j.vaccine.2013.05.073.
5. de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. 2008. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr. Infect. Dis. J. 27:218-223.
6. Mills KH. 2001. Immunity to Bordetella pertussis. Microbes Infect. 3:655-677.
7. Trollfors B, Taranger J, Lagergard T, Lind L, Sundh V, Zackrisson G, Lowe CU, Blackwelder W, Robbins JB. 1995. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333:1045-1050.
8. Storsaeter J, Hallander HO, Gustafsson L, Olin P. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
9. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. 1997. Vaccineand antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
10. +T cells for key functions other than specific antibody production. J. Exp. Med. 191:1841-1852.
11. Rieber N, Graf A, Hartl D, Urschel S, Belohradsky BH, Liese J. 2011. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response. PLoS One 6:e17271. doi:10.1371/journal.pone.0017271.
12. Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L, Oymar K, Miller E, Storsaeter J, Mills KH. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
13. Tran Minh NN, He Q, Edelman K, Olander RM, Viljanen MK, Arvilommi H, Mertsola J. 1999. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. Pediatr. Infect. Dis. J. 18:366-370.
14. Taranger J, Trollfors B, Lagergard T, Sundh V, Bryla DA, Schneerson R, Robbins JB. 2000. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J. Infect. Dis. 181:1010-1013.
15. Ausiello CM, Lande R, Urbani F, Di Carlo B, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A. 2000. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J. Infect. Dis. 181:1989-1995.
16. Giammanco A, Taormina S, Chiarini A, Dardanoni G, Stefanelli P, Salmaso S, Mastrantonio P. 2003. Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough. Vaccine 21:1924-1931.
17. Coffman RL, Lebman DA, Rothman P. 1993. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54:229-270.
18. Hendrikx LH, de Rond LG, Ozturk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM. 2011. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Vaccine 29:5725-5730.
19. Schure RM, Hendrikx LH, de Rond LGH, Ozturk K, Sanders EAM, Berbers GAM, Buisman AM. 2012. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children. Clin. Vaccine Immunol. 19:1879-1886.
20. Loosmore SM, Yacoob RK, Zealey GR, Jackson GE, Yang YP, Chong PS, Shortreed JM, Coleman DC, Cunningham JD, Gisonni L, Klein MH. 1995. Hybrid genes over-express pertactin from Bordetella pertussis. Vaccine 13:571-580.
21. van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA. 2008. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods 335:79-89.
22. Long SS, Welkon CJ, Clark JL. 1990. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J. Infect. Dis. 161:480-486.
23. Versteegh FG, Mertens PL, de Melker HE, Roord JJ, Schellekens JF, Teunis PF. 2005. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol. Infect. 133:737-748.
24. Hendrikx LH, Schure RM, Ozturk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM. 2011. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine 29:6874-6880.
25. Buisman AM, de Rond CG, Ozturk K, Ten Hulscher HI, van Binnendijk RS. 2009. Long-term presence of memory B-cells specific for different vaccine components. Vaccine 28:179-186.
26. + cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J. Immunol. Methods 278:79-93.
27. Jacobson JW, Oliver KG, Weiss C, Kettman J. 2006. Analysis of individual data from bead-based assays ("bead arrays"). Cytometry A 69:384-390.
28. Hanley BP. 2008. Variance in multiplex suspension array assays: a distribution generation machine for multiplex counts. Theor. Biol. Med. Model. 5:3. doi:10.1186/1742-4682-5-3.
29. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. 2012. Waning protection after fifth dose of acellular pertussis vaccine in children. N. Engl. J. Med. 367:1012-1019.
30. Witt MA, Katz PH, Witt DJ. 2012. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin. Infect. Dis. 54:1730-1735.
31. Giuliano M, Mastrantonio P, Giammanco A, Piscitelli A, Salmaso S, Wassilak SG. 1998. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J. Pediatr. 132:983-988.
32. Hallander HO, Gustafsson L, Ljungman M, Storsaeter J. 2005. Pertussis antitoxin decay after vaccination with DTPa: response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. Vaccine 23:5359-5364.
33. Meyer CU, Habermehl P, Knuf M, Hoet B, Wolter J, Zepp F. 2008. Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation. Hum. Vaccin. 4:203-209.
34. Sänger R, Behre U, Krause KH, Loch HP, Soemantri P, Herrmann D, Schmitz-Hauss E, Wolter J, Hoet B. 2007. Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine. Eur. J. Pediatr. 166:1229-1236.
35. Mertsola J, Van Der Meeren O, He Q, Linko-Parvinen A, Ramakrishnan G, Mannermaa L, Soila M, Pulkkinen M, Jacquet JM. 2010. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin. Infect. Dis. 51:656-662.
36. Isacson J, Trollfors B, Taranger J, Lagergard T. 1995. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr. Infect. Dis. J. 14:517-521.
37. Finkelman FD, Holmes J, Katona IM, Urban JF, Jr, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
38. Mascart F, Hainaut M, Peltier A, Verscheure V, Levy J, Locht C. 2007. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 25:391-398.
39. Schure RM, de Rond L, Ozturk K, Hendrikx L, Sanders E, Berbers G, Buisman AM. 2012. Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age. PLoS One 7:e41928. doi:10.1371/journal.pone.0041928.
40. Hendrikx LH, Ozturk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM. 2011. Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics. PLoS One 6:e27681. doi:10.1371/journal.pone.0027681.
41. Queenan AM, Cassiday PK, Evangelista A. 2013. Pertactin-negative variants of Bordetella pertussis in the United States. N. Engl. J. Med. 368: 583-584.